All Cases

Investor Support

Developed a rare liver disease market landscape for an investment group looking to identify potential acquisition targets for an expansion to the U.S. market and performed commercial due diligence resulting in an acquisition of over $2B

Oncology acquisition and licensing deal benchmarking for healthcare investment firm

Defined investment criteria, including the business model and P&L, allowing an investment management company seeking to expand their life sciences practice

Post-merger portfolio and commercialization integration for a mid-size Neurology company